CAJ | 학술논문

目的：观察肝癌介入栓塞治疗术前和术后口服盐酸羟考酮控释片(奥施康定)疼痛治疗效果及其不良反应,探讨合理可行的介入栓塞治疗镇痛方法。方法：90例肝癌介入栓塞术患者,术前1h口服奥施康定10mg,术后口服奥施康定10mg q12h×3d,观察统计镇痛效果及相关副作用。结果：术后12h疼痛发生率为32.2%,24h为8.9%,术后48h后疼痛发生率稳定在3.3%,其中重度疼痛发生率为0。结论：口服奥施康定可有效控制肝癌介入栓塞治疗术中和术后的疼痛,不良反应轻,服用安全。
목적：관찰간암개입전새치료술전화술후구복염산간고동공석편(오시강정)동통치료효과급기불량반응,탐토합리가행적개입전새치료진통방법。방법：90례간암개입전새술환자,술전1h구복오시강정10mg,술후구복오시강정10mg q12h×3d,관찰통계진통효과급상관부작용。결과：술후12h동통발생솔위32.2%,24h위8.9%,술후48h후동통발생솔은정재3.3%,기중중도동통발생솔위0。결론：구복오시강정가유효공제간암개입전새치료술중화술후적동통,불량반응경,복용안전。
Objective:To observe the analgesic effect and adverse effect of oral administration Oxycontin (Oxycodone Hydrochloride Controlled- release Tablets) before and after Transcatheter arterial chemoembolization (TACE) treatment of hepatic carcinoma,discuss the reasonable and feasible pain control method for TACE.Methods:90 patients were given 10mg Oxycontin 1h before the interventional therapy,and after operation 10mg for every 12h for 3 days.The efficacy and side effects were observed and recorded. Results:12 and 24 hours after interventional therapy,the incidences of pain were respectively 32.2% and 8.9%.48h after TACE,the incidences of pain were remained around 3.3%.Among all patients,incidence of severe pain is zero.Conclusion:Oral treatment of Oxycontin can be effective in controlling pain of interventional therapy in hepatic carcinoma,less adverse reactions and take safety.